Skip to main content
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. logo

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings

Ticker · 688238 ISIN · CNE1000059N9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 486 across all filing types
Latest filing 2023-04-19 Governance Information
Country CN China
Listing Shanghai Stock Exchange 688238

About SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD.

https://www.obio-tech.com/

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.

Recent filings

Filing Released Lang Actions
《董事会议事规则》
Governance Information Classification · 100% confidence The document is titled '董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors' of a company. It details the structure, responsibilities, duties, meeting procedures, and governance related to the board of directors. It references company law, governance codes, and internal company rules. There is no financial data, no audit report, no earnings information, no voting results, no announcement of a report, nor any other regulatory filing or announcement. The content is focused on governance practices and internal rules of the board. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance rules, supporting a high confidence in classification.
2023-04-19 Chinese
《对外担保管理制度》
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and is issued by 和元生物技术（上海）股份有限公司. It outlines the company's internal policies and procedures for managing external guarantees, including approval processes, risk control, responsibilities, and compliance with laws and regulations. The document is a governance or internal control policy document rather than a financial report, announcement, or regulatory filing. It does not contain financial statements, audit results, voting results, or any form of earnings or capital update. It is a detailed governance-related document about company practices and internal rules. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 3640 characters, which is consistent with a policy document rather than a brief announcement or a full report.
2023-04-19 Chinese
关于继续使用暂时闲置募集资金进行现金管理的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement by a company regarding the continued use of temporarily idle raised funds for cash management. It details board and supervisory approvals, investment purposes, risk controls, and regulatory compliance related to the use of idle raised funds. The document references regulatory approvals, board meeting resolutions, and independent opinions but does not contain financial statements or comprehensive financial performance data. It is a regulatory announcement about the use of raised funds rather than a financial report or earnings release. The document length is about 4600 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2023-04-19 Chinese
非经营性资金占用及其他关联资金往来情况的专项审计报告
Audit Report / Information Classification · 95% confidence The document is titled as a "专项审计说明" (special audit explanation) regarding non-operating fund occupation and other related party fund transactions for the year 2022. It includes an audit opinion from a registered accounting firm and references compliance with regulatory guidelines for listed companies' fund transactions and guarantees. The document contains an audit conclusion specifically on the special audit of related party fund usage, not a full annual report or financial statements. It is a standalone audit report focusing on a specific audit area, consistent with the definition of an Audit Report / Information (AR). The document length is 2555 characters, which is sufficient for a detailed audit report but not a brief announcement. Therefore, the classification is AR with high confidence. FY 2022
2023-04-19 Chinese
《薪酬管理制度》
Remuneration Information Classification · 95% confidence The document is a detailed internal policy titled '薪酬管理制度' (Compensation Management System) for a company, describing salary management principles, organizational responsibilities, salary structure, adjustment procedures, and confidentiality rules. It is a company internal governance document related to remuneration and compensation management, not a financial report, earnings release, or regulatory filing. It does not contain financial statements, audit information, or shareholder meeting materials. It specifically details compensation policies and procedures, which aligns with the definition of Remuneration Information (DEF 14A).
2023-04-19 Chinese
2022年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the 2022 annual report summary of a company (和元生物技术（上海）股份有限公司). It contains detailed information about the company's business, industry background, risk factors, financial performance, and future plans. It references the full annual report and includes audited financial results, profit distribution plans, and comprehensive management discussion and analysis. The length is substantial (15,000 characters), and it is not merely an announcement or a certification. The content aligns with the characteristics of an Annual Report (10-K) as it covers company activity and full financial performance for the fiscal year 2022. FY 2022
2023-04-19 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.